Balancing Expectations for Success in Stem Cell-Based Clinical Trials for Parkinson's Disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 33007236.
- Also identified by DOI 10.1016/j.stem.2020.09.002.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Upcoming clinical trials assessing transplantation of stem cell-derived dopaminergic neurons into the striatum in patients with Parkinson's disease could generate groundbreaking results on neuronal replacement in the human brain. However, as highlighted here, the road toward a clinically competitive treatment for this multisystem disorder will probably be long and winding.
Medical subject headings
- Parkinson Disease